title: Clinical experiences with nimodipine in cerebral ischemia.
abstract: Increased intracellular calcium is involved in the death of neurons associated with cerebral ischemia. After extensive experimental work, the calcium antagonist nimodipine has been investigated in several clinical trials in patients with disorders of the cerebral circulation. A short overview on trials in subarachnoid hemorrhage, head injury, ischemic stroke and cerebral resuscitation is given in this paper.
authors.affiliation: Medical Research CNS, Troponwerke GmbH & Co. KG, Köln, Federal Republic of Germany.
authors.forename: A
authors.initials: A
authors.lastname: Kakarieka
authors.forename: E H
authors.initials: EH
authors.lastname: Schakel
authors.forename: J
authors.initials: J
authors.lastname: Fritze
mesh_terms: D002545:Brain Ischemia / Q000188:drug therapy*; D002561:Cerebrovascular Disorders / Q000188:drug therapy; D002986:Clinical Trials as Topic; D006259:Craniocerebral Trauma / Q000188:drug therapy; D006801:Humans; D009553:Nimodipine / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012151:Resuscitation; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy
chemical_list: D009553:Nimodipine